The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy.
FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flaws
Written by
in
Clinical Trials, Depression (Mental), Drug Abuse and Traffic, Drug Enforcement Administration, Drugs (Pharmaceuticals), Ecstasy (Drug), Food and Drug Administration, MAPS Public Benefit Corp, Mental Health and Disorders, Placebos, Post-Traumatic Stress Disorder, Psychedelic and Hallucinogenic Drugs, Regulation and Deregulation of Industry, Research, Therapy and Rehabilitation, Veterans